pre-IPO PHARMA

COMPANY OVERVIEW

Izun Pharmaceuticals Ltd. is an emerging biopharmaceutical company with a product portfolio of powerful non-steroidal topical oral anti-inflammatory therapies with superior efficacy and safety to current periodontal treatments.


LOCATION

  • New York, NY, USA
  • Jerusalem, , Israel

  • THERAPEUTIC AREAS

  • Dermatology

  • WEBSITE

    https://izunpharma.com/


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Oct 11, 2017

    Izun Pharmaceuticals Announces Positive Results from Phase 2 Double Blind Oral Mucositis Trial


    Mar 6, 2017

    Izun Pharmaceuticals Announces Approval of Curasite™ Hydrogel Wound Care Product by FDA


    Jan 5, 2016

    Izun Pharmaceuticals to Present at Biotech Showcase 2016


    Oct 13, 2015

    Izun Pharmaceuticals Announces Positive Results from Phase 2 Randomized Trial in Diabetic Foot Ulcers


    Jul 22, 2015

    Izun Pharmaceuticals Corp Appoints Jack Talley as Chief Executive Officer


    For More Press Releases


    Google Analytics Alternative